| Labcorp

June 6, 2021

Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review and meta-analysis

August 12, 2021

Labcorp extends leadership in women’s health with acquisition of Ovia Health

BURLINGTON, N.C. --(BUSINESS WIRE)--Aug. 12, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has acquired Ovia Health , a digital health platform used by millions of women seeking information and support with family planning, pregnancy and parenting.

COVID-19 vs. Flu vs. RSV: How to tell the difference between respiratory infections

Learn the differences between the flu, COVID-19, and RSV and ways to diagnose them.

A Guide to the COVID-19 Variants: What You Need to Know About Testing and More

Learn about the multiple SARS-CoV-2 variants that have emerged since the start of the pandemic.

A Guide To COVID-19 Testing For Small Businesses

Helping your business get back to work safely.

COVID-19 Testing Options to Detect Current Infection vs. Prior Infection

Get a better understanding of COVID-19 testing options – from what each type of test actually detects to sample collection and results. Know the facts to determine what’s best for you.

August 5, 2021

National Kidney Foundation and Labcorp data show millions are not tested for kidney disease

NEW YORK, Aug. 5, 2021 - New data suggest that millions of patients most at-risk for life-threatening kidney disease are unaware they have it because they are not tested according to clinical practice guidelines despite their risk.

Kümmern Sie sich um Ihre Gesundheit

Krankheiten und Therapiebereiche

Behandlungsmodalitäten und -methoden

Wissenschaftliche Labordisziplinen

Labore

Branchen